Market Size of Respiratory Protection Equipment Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Respiratory Protection Equipment Market Analysis
The respiratory protection equipment market is projected to register a CAGR of 6.5% during the forecast period.
The COVID-19 outbreak spiked the demand for healthcare protective equipment due to the high number of cases globally. Several regulatory organizations have recommended various companies and governments to increase their manufacturing capacity of respiratory protective equipment, including respirators and breathing apparatuses, which boosted the market during the pandemic. According to the CDC, in December 2022, the highly-contagious Omicron subvariant XBB was estimated for 18.3% of the COVID-19 cases in the United States, an increase from 11.2% in the past week. Hence, the rising number of new cases of COVID-19 increased the demand for respiratory protection equipment. This rising demand may also drive the market in the coming years.
The growing burden of the pandemic and other epidemic diseases, increasing demand for surgical procedures, including minimally invasive procedures, and increasing importance given to workplace safety are some of the factors driving the overall market's growth. For instance, as per the WHO report published in December 2022, FluNet received data from the National Influenza Centers (NICs) and other national influenza laboratories of 130 nations, regions, or territories between November 28 and December 11, 2022. Over 447,351 samples were analyzed by the WHO GISRS laboratories throughout this period. There were 81,619 influenza virus positives, out of which 79,209 (97%) were influenza A and 2,410 (3%) were influenza B. About 11,791 (71.4%) and 4,722 (28.6%) of the sub-typed influenza A viruses were influenza A (H1N1 and H3N2, respectively). These figures indicate the high burden of influenza, which requires proper respiratory protection using equipment. This factor is expected to drive the market over the forecast period.
In February 2022, Nelson Labs launched the Nelson Labs Mark, a verification program for product testing that authenticates test reports and provides reliable data on product performance. The new offering empowers consumers to make informed decisions when purchasing face masks and respirators and provides credible manufacturers with the means to differentiate their products from others in the market.
However, the high cost of respirators and presence of substandard respirators and issues regarding disposal and reusability of equipment are expected to hinder the growth of the market.
